![]() ![]() Anvita has more than nine years of experience in artificial intelligence domains, including generative modeling, computer vision, and natural language processing for genomics, proteomics, and drug design for global academic labs at Stanford University, Harvard Medical School, and ETH Zurich. is leveraging this unique interdisciplinary opportunity afforded by massively growing biomedical datasets, modern machine learning algorithms, and growing unmet medical needs in order to accomplish our mission of enabling data-driven discovery of novel biologic therapeutics and diagnostics for patients.Īnvita Gupta is CEO of AINovo™ Biotech. Cutting-edge artificial intelligence algorithms in computer vision, natural language processing, and generative machine learning have matured and can be brought to bear on these curated datasets to enable data-driven decision making in pharmaceutical R&D problems.ĪINovo™ Biotech Inc. Biologics such as therapeutic antibodies have transformed the field of oncology and led to transformative cancer immunotherapy treatments.Īt the same time, the increase in genomic sequencing, proteomic data, real world evidence, and electronic health records have led to a wealth of available information which can be leveraged to extract relevant pharmaceutical insights. Protein-based therapeutics are at the forefront of biomedical research, and have been used to treat a variety of conditions with unmet medical needs.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
June 2023
Categories |